|Bid||122.71 x 1200|
|Ask||122.83 x 1300|
|Day's range||122.59 - 125.16|
|52-week range||117.08 - 189.07|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||2.99|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||02 June 2022|
|1y target est||N/A|
Wynn Resorts and BioNTech have been highlighted as Zacks Bull and Bear of the Day.
BNTX is ranked a lowly 5 for a reason. Earnings have peaked, COVID hysteria has subsided, and the technical picture is lagging.
Shares of vaccine maker BioNTech (NASDAQ: BNTX) were down 2.8% early Monday afternoon after falling as much as 6.4% earlier in the day. Annual earnings per share (EPS) also dropped a bit, from 39.63 euros ($42.76) to 37.77 euros ($40.77). In the long run, BioNTech may still be a good deal.